Novavax Inc (NVAX)

53.55
+1.88(+3.64%)
  • Volume:
    3,131,753
  • Day's Range:
    50.20 - 53.70
  • 52 wk Range:
    34.88 - 277.80

NVAX Overview

Prev. Close
51.67
Day's Range
50.2-53.7
Revenue
1.4B
Open
51.91
52 wk Range
34.88-277.8
EPS
-17.69
Volume
3,131,753
Market Cap
4.16B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
6,009,398
P/E Ratio
-
Beta
1.6
1-Year Change
-72.78%
Shares Outstanding
78,134,595
Next Earnings Date
04 Aug 2022
What is your sentiment on Novavax?
or
Vote to see community's results!

Novavax Inc Analysis

Novavax Inc Company Profile

Novavax Inc Company Profile

Employees
1541

Novavax, Inc., along with its wholly owned subsidiaries, Novavax AB and Novavax CZ, is a biotechnology company. The Company promotes improved health globally through the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its recombinant technology platform harnesses the power and speed of genetic engineering to produce immunogenic nanoparticles designed to address urgent global health needs. The vaccine candidates in its near-term pipeline, including both coronavirus vaccine candidate (NVX-CoV2373) and seasonal quadrivalent influenza vaccine candidate (NanoFlu), which are genetically engineered, three-dimensional nanostructures of recombinant proteins critical to disease pathogenesis. NVX-CoV2373 is marketed under the brand name of Covovax or as Nuvaxovid COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell